Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs

被引:135
作者
Hu, ZL
Yang, XY
Liu, YB
Morse, MA
Lyerly, HK
Clay, TM
Zhong, P [1 ]
机构
[1] Duke Univ, Dept Mech Engn & Mat Sci, Durham, NC 27708 USA
[2] Duke Univ, Program Mol Therapeut, Dept Surg, Durham, NC 27708 USA
[3] Duke Univ, Dept Med, Durham, NC 27708 USA
[4] Duke Univ, Dept Pathol & Immunol, Durham, NC 27708 USA
[5] Duke Univ, Ctr Comprehens Canc, Durham, NC 27708 USA
关键词
high-intensity focused ultrasound; endogenous danger signals; antigen-presenting cells; anti-tumor immunity;
D O I
10.1016/j.bbrc.2005.07.071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The effects of high-intensity focused ultrasound (HIFU) on the release of endogenous danger signals from tumor cells and subsequent activation of antigen-presenting cells (APCs) were evaluated in vitro. MC-38 mouse tumor cells were treated using a 1.1 MHz HIFU transducer under two different protocols (P- = 6.7 MPa, 30% duty cycle, 5 s vs. P- = 10.7 MPa, 3% duty cycle, 30 s) to produce either thermal necrosis or mechanical lysis of the tumor cells. Here, we report that HIFU treatment can cause the release of endogenous danger signals (ATP and hsp60) and exposure of dendritic cells (DCs) and macrophages to the supernatants of HIFU-treated tumor cells leads to an increased expression of co-stimulatory molecules (CD80 and CD86) with enhanced secretion of IL-12 by the DCs and elevated secretion of TNF-alpha by the macrophages. The potency in APC activation produced by mechanical lysis is much stronger than thermal necrosis of the tumor cells. These findings suggest that optimization of treatment strategy may help to enhance HIFU-elicited anti-tumor immunity. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:124 / 131
页数:8
相关论文
共 34 条
[1]
BANCHEREAU J, 1997, NATURE, V388, P787
[2]
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway [J].
Basu, S ;
Binder, RJ ;
Suto, R ;
Anderson, KM ;
Srivastava, PK .
INTERNATIONAL IMMUNOLOGY, 2000, 12 (11) :1539-1546
[3]
Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cells [J].
Buttiglieri, S ;
Galetto, A ;
Forno, S ;
De Andrea, M ;
Matera, L .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) :516-520
[4]
CELIA M, 1997, CURR OPIN IMMUNOL, V9, P10
[5]
The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection [J].
Christian Chaussy ;
Stefan Thüroff .
Current Urology Reports, 2003, 4 (3) :248-252
[6]
Treatment of implanted liver tumors with focused ultrasound [J].
Chen, LL ;
Ter Haar, G ;
Hill, CR ;
Eccles, SA ;
Box, G .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1998, 24 (09) :1475-1488
[7]
Chen W, 1999, J IMMUNOL, V162, P3212
[8]
Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation [J].
Drent, M ;
Cobben, NAM ;
Henderson, RF ;
Wouters, EFM ;
vanDieijenVisser, M .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (08) :1736-1742
[9]
Natural adjuvants: Endogenous activators of dendritic cells [J].
Gallucci, S ;
Lolkema, M ;
Matzinger, P .
NATURE MEDICINE, 1999, 5 (11) :1249-1255
[10]
Danger signals: SOS to the immune system [J].
Gallucci, S ;
Matzinger, P .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (01) :114-119